Lates News

Every AI Express, Zhongyin Securities issued a research report on April 28, giving Roche Holdings (002793.SZ) a "buy" rating. The main reasons for the rating include: 1) The core product Toradol has achieved rapid volume growth, restructuring the business structure to shift from short-term contraction to long-term high-quality development; 2) Structural highlights are prominent, and the digestive system business has become a core pillar of the company; 3) Gross profit margin continues to improve, cost control effectiveness is evident, and operating cash flow has improved significantly. (Daily Economic News)